NZ govt: "Viagra found in alternative medicine"

25 March 2007

A new agreement with Australia on regulating alternative medicines in New Zealand has been justified on the grounds that prescription drugs have been mixed into some complementary products. Responding to questions in the New Zealand Parliament about the proposed Therapeutic Products and Medicines Bill and how it affects alternative medicines, Annette King, the Minister of State Services, said: "New Zealand's existing therapeutic products law is outdated and unsustainable, and does not adequately manage the public health risks associated with the use of complimentary medicines."

Ms King added that three deaths and other adverse reactions have been reported to New Zealand's monitoring authorities. She said: "complementary medicines have been found to be adulterated with pharmaceutical medicines - such as Viagra [sildenafil] - or to contain dangerous amounts of heavy metals, such as lead." Global drug giant Pfizer's erectile dysfunction drug is considered to be the product most commonly targeted by counterfeiters (Marketletters passim).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight